StockData
Citius Pharmaceuticals, Inc. logo

Citius Pharmaceuticals, Inc. (CTXR) stock

CTXRNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$0.52−0.01 (-1.67%)

Close on Nov 17, 2026Market cap $14.24MP/E –Yield –

Citius Pharmaceuticals operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Citius Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$34.87M. For fiscal 2025 it was -$26.55M. The highest annual figure on record is -$20.32K in fiscal 2012.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Sep 30, 2025-$26.55M–
FY2024Sep 30, 2024-$28.20M–
FY2023Sep 30, 2023-$29.06M–
FY2022Sep 30, 2022-$28.36M–
FY2021Sep 30, 2021-$24.25M–
FY2020Sep 30, 2020-$16.93M–
FY2019Sep 30, 2019-$12.44M–
FY2018Sep 30, 2018-$11.32M–
FY2017Sep 30, 2017-$7.97M–
FY2016Sep 30, 2016-$5.90M–
FY2012Sep 30, 2012-$20.32K–
FY2011Sep 30, 2011-$20.78K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026-$8.68M–
Q2 FY2026CQ1 2026Mar 31, 2026-$1.30M–
Q1 FY2026CQ4 2025Dec 31, 2025-$13.01M–
Q4 FY2025CQ3 2025Sep 30, 2025-$11.88M–
Q3 FY2025CQ2 2025Jun 30, 2025-$5.41M–
Q2 FY2025CQ1 2025Mar 31, 2025-$4.54M–
Q1 FY2025CQ4 2024Dec 31, 2024-$4.73M–
Q4 FY2024CQ3 2024Sep 30, 2024-$5.91M–
Q3 FY2024CQ2 2024Jun 30, 2024-$8.37M–
Q2 FY2024CQ1 2024Mar 31, 2024-$7.79M–
Q1 FY2024CQ4 2023Dec 31, 2023-$6.14M–
Q4 FY2023CQ3 2023Sep 30, 2023-$6.80M–
Q1 FY2023CQ4 2022Dec 31, 2022-$4.82M–
Q4 FY2022CQ3 2022Sep 30, 2022-$6.33M–
Q3 FY2022CQ2 2022Jun 30, 2022-$7.71M–
Q2 FY2022CQ1 2022Mar 31, 2022-$9.67M–
Q1 FY2022CQ4 2021Dec 31, 2021-$4.65M–
Q4 FY2021CQ3 2021Sep 30, 2021-$5.59M–
Q3 FY2021CQ2 2021Jun 30, 2021-$4.82M–
Q2 FY2021CQ1 2021Mar 31, 2021-$4.27M–
Q1 FY2021CQ4 2020Dec 31, 2020-$9.56M–
Q4 FY2020CQ3 2020Sep 30, 2020-$3.36M–
Q3 FY2020CQ2 2020Jun 30, 2020-$3.99M–
Q2 FY2020CQ1 2020Mar 31, 2020-$4.47M–
Q1 FY2020CQ4 2019Dec 31, 2019-$5.11M–
Q4 FY2019CQ3 2019Sep 30, 2019-$2.91M–
Q3 FY2019CQ2 2019Jun 30, 2019-$3.52M–
Q2 FY2019CQ1 2019Mar 31, 2019-$3.85M–
Q1 FY2019CQ4 2018Dec 31, 2018-$2.16M–
Q4 FY2018CQ3 2018Sep 30, 2018-$2.50M–
Q3 FY2018CQ2 2018Jun 30, 2018-$2.25M–
Q2 FY2018CQ1 2018Mar 31, 2018-$4.13M–
Q1 FY2018CQ4 2017Dec 31, 2017-$2.44M–
Q4 FY2017CQ3 2017Sep 30, 2017-$3.43M–
Q3 FY2017CQ2 2017Jun 30, 2017-$2.40M–
Q2 FY2017CQ1 2017Mar 31, 2017-$824.60K–
Q1 FY2017CQ4 2016Dec 31, 2016-$1.31M–
Q4 FY2016CQ3 2016Sep 30, 2016-$1.77M–
Q3 FY2016CQ2 2016Jun 30, 2016-$2.56M–

More Citius Pharmaceuticals figures

See a number that looks wrong?